RIGEL PHARMACEUTICALS INC (RIGL) Stock Analyst Ratings
USA - NASDAQ:RIGL - US7665597024 - Common Stock
30.65 USD
-0.93 (-2.94%)
30.6331 USD
-0.02 (-0.06%)
ChartMill assigns a Buy % Consensus number of 77% to RIGL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 39.1. This target is 27.57% above the current price.
RIGL was analyzed by 12 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about RIGL.
In the previous month the buy percentage consensus was at a similar level.
RIGL was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-06 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2025-05-07 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2025-03-06 | Citigroup | Maintains | Buy -> Buy |
| 2025-03-05 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2025-03-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-10 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2024-12-10 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-06 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2024-11-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-12 | Citigroup | Maintains | Buy -> Buy |
| 2024-10-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-09-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-07 | Citigroup | Maintains | Buy -> Buy |
| 2024-03-06 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2024-03-06 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2024-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
RIGEL PHARMACEUTICALS INC / RIGL FAQ
What is the price target for RIGL stock?
12 analysts have analysed RIGL and the average price target is 39.1 USD. This implies a price increase of 27.57% is expected in the next year compared to the current price of 30.65.
How do analysts rate RIGEL PHARMACEUTICALS INC (RIGL)?
The consensus rating for RIGEL PHARMACEUTICALS INC (RIGL) is 76.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for RIGL stock?
The number of analysts covering RIGEL PHARMACEUTICALS INC (RIGL) is 12.